Treatment of HER2-positive metastatic breast cancer - The authors reply Journal Article
| Authors: | Swain, S. M.; Clark, E.; Baselga, J. |
| Article Title: | Treatment of HER2-positive metastatic breast cancer - The authors reply |
| Keywords: | treatment outcome; overall survival; cancer recurrence; placebo; treatment duration; letter; clinical practice; breast cancer; cancer mortality; docetaxel; early cancer; hazard ratio; observational study; trastuzumab; epidermal growth factor receptor 3; breast metastasis; pertuzumab; human; priority journal |
| Journal Title: | New England Journal of Medicine |
| Volume: | 372 |
| Issue: | 20 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2015-05-14 |
| Start Page: | 1964 |
| End Page: | 1965 |
| Language: | English |
| DOI: | 10.1056/NEJMc1503446 |
| PUBMED: | 25970056 |
| PROVIDER: | scopus |
| PMCID: | PMC4980989 |
| DOI/URL: | |
| Notes: | Export Date: 3 June 2015 -- Source: Scopus |
